<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82191">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01769248</url>
  </required_header>
  <id_info>
    <org_study_id>FNAFNBmucin</org_study_id>
    <nct_id>NCT01769248</nct_id>
  </id_info>
  <brief_title>Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle</brief_title>
  <acronym>MUCIN</acronym>
  <official_title>Randomized Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic ultrasound (EUS) is paramount in the diagnosis and evaluation of cancers
      involving the gastrointestinal tract. EUS allows for the acquisition of cellular (fine
      needle aspirate - FNA) or tissue biopsy (fine needle biopsy - FNB) for diagnostic purposes.
      This has traditionally been done with fine needle aspirate where a needle is inserted into
      the tumor and potentially malignant cells are extracted for microscopic analysis. More
      recently, a needle that allows a tissue biopsy for histologic analysis has been FDA
      approved.

      The Echotip Procore (Cook Medical) core biopsy needle (ETP), has been demonstrated to
      provide excellent efficacy for core biopsy samples. Final diagnostic yield using this needle
      ranges from 80-90% and appears to be significantly greater than EUS-FNA for lesions
      requiring histology for diagnosis. However, there is currently only limited data from
      prospective studies comparing EUS-FNA to EUS-FNB with the ETP needle. The investigators
      propose a randomized, prospective, cross-over study comparing diagnostic accuracy of EUS-FNA
      to EUS-FNB.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Diagnostic Yield of EUS-FNB</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators' primary outcome measure will assess the diagnostic yield (%) of EUS-FNB (fine-needle biopsy) to provide a final diagnosis of the lesion being sampled. This will be expressed as a percentage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specimen adequacy as assessed by Rapid-onsite evaluation of FNA and FNB</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators' secondary outcome will assess the ability to obtain an adequate specimen for in room cytologic evaluation as determined by our cytopathologist. This will be defined as a sample that is representative (not necessarily diagnostic) of the lesion in question. This will be expressed as a percentage and compared between FNA and FNB</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Pancreatic Mass</condition>
  <condition>Abnormal Lymph Nodes</condition>
  <condition>Mediastinal Masses</condition>
  <condition>Gastric Submucosal Masses</condition>
  <arm_group>
    <arm_group_label>FNA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fine needle aspiration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FNB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fine needle biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fine needle aspiration</intervention_name>
    <description>Fine needle aspiration</description>
    <arm_group_label>FNA</arm_group_label>
    <other_name>Echo Tip FNA Needle</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fine needle biopsy</intervention_name>
    <description>FNB</description>
    <arm_group_label>FNB</arm_group_label>
    <other_name>Echo Tip Procore</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - 3.1.1 All patients referred for EUS tissue sampling who provide informed consent

        Exclusion Criteria:

          -  3.2.1 Coagulopathy which is not corrected

        3.2.2 Diagnostic EUS determines lesion is not amenable to FNA or FNB
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Srinadh Komanduri</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Srinadh Komanduri</last_name>
    <phone>3129334873</phone>
    <email>koman1973@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raman Muthusamy, MD</last_name>
      <phone>310-825-9111</phone>
      <email>Raman@mednet.ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janak Shah, MD</last_name>
      <phone>415-845-8476</phone>
      <email>ShahJ@sutterhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Moffit Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jason Klapman, MD</last_name>
      <phone>813-745-4673</phone>
      <email>jklapman@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 18, 2014</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Sri Komanduri</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>EUS</keyword>
  <keyword>FNA</keyword>
  <keyword>FNB</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Marfan Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
